medigraphic.com
ISSN 1561-3062 (Electronic)

2013, Number 4

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2013; 39 (4)

Climacteric, vascular damage and sexuality

Lugones BM

Language: Spanish
References: 42
Page: 413-426
PDF size: 71.98 Kb.


ABSTRACT

Women in climacteric and menopause stages are in a period of change ranging from the biological to the social contexts and they are often associated chronic non-communicable diseases such as vascular disease of atherosclerotic origin. It has long been recognized that postmenopausal women are at increased risk of vascular disease. Hormonal factors, especially the decrease in estradiol concentrations influence, so that morbidity acquires an important role, especially when taking into account, that around one third of a woman's life elapses after menopause. Sexuality and full enjoyment is essential at this stage. Women capacity of sexual enjoyment does not stop, although sexual response may diminish due to estrogen cycle drops during this stage. Estrogens indirectly influence sexual desire to contribute to the positive feedback of sexual response in the excitement phase, and they have a role in facilitating vasodilation, they protect the clitoral, vaginal and urethral circulation described as preventive effect of atherosclerosis in pelvic territories. They favor tropism of the vaginal walls and vaginal lubrication, most obvious effect in postmenopausal women when these levels decline. Hormonal and circulatory physiology of the female genitalia are factors to be always present in sexuality, while considering the social and psychological aspects are also of great importance.


REFERENCES

  1. Colectivo de autores. II Consenso Nacional de Climaterio y Menopausia. En: Sarduy Nápoles M , Lugones Botell M, editores. La Habana: Editorial CIMEQ; 2007.

  2. Karen Matthews, Kim Sutton-Tyrrell. ¿Qué hay de nuevo acerca de la menopausia y el riesgo cardiovascular? Revista de Climaterio. 2011;14(81):80-4.

  3. Shaw LJ, Bugiardini R, Bairey Merz CN. Women and ischemic heart disease: Evolving knowledge. J Am Coll Cardiol. 2009;54:1561-75.

  4. Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction. Eur Urol. 2001;8:225-34.

  5. Goldstein I, Traish A. The role of sexual steroid hormone in female sexual function and dysfunction. Clin Obstet and Gynecol. 2002;49:471-8.

  6. Gregersen N, Jensen PT, Giraldi AE. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication. Dan Med Bull. 2006;53(3):349-53.

  7. Kinsey A. La conducta sexual en el hombre y la mujer. Editorial. Bloomington: Siglo XX; 1970.

  8. Meston CM. Validation of the female sexual function index (FSFI in women whit female orgasmic disorder and in women in with female orgasmic disorder and in women whit hypoactive sexual desire disorder. J Sex Marital Ther. 2003;29:39-46.

  9. Chedraui P, Pérez-López FR, San Miguel G, Ávila C. La valoración de sexualidad entre mujeres de mediana edad. Uso del índice de la función sexual en mujeres. Climacteric. 2009;12:213-21.

  10. Safarinejad SR. Female sexual dysfunction in a population- based study in Iran: prevalence and associated risk factors. Int J Impot Res. 2006;18:382-95.

  11. Wellons M. Junio 21, 2010. Reuters [consultado 22 Nov 2012]. Disponible en: http://www.endo-society.net/about/index.cfm

  12. Williams RE, Kalilani L, Bibenedetti DB, Zhou X. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008;11:32-43.

  13. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, MatthewsKA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation. 2008;118:1234-40.

  14. Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause. 2010;17:256-61.

  15. Hernández Mesa N, Anías Calderón J. Estrés. Rev Cubana Med Gen Integr. 1992;8(3):261-70.

  16. Szekacs B, Vajo Z, Acs N, Hada P, Ssuzi L, Bezeredi J. Woman´s Healthy Lifestyle Study. Journal of the American College of Cardiology. 2009;49:579-85.

  17. Skrzypulec V, Dabrowska J, Drosdzol A. The influence of physical activity level on climacteric symptoms in menopausal women. Climacteric. 2010;13:35561.

  18. Palacio ML. Sexualidad femenina en el climaterio [consultado 4 Feb 2013]. Disponible en: http://www.encolombia.com

  19. Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Human Hypertens. 2008;12(9):587-92.

  20. Izumi Y, Matsumoto K, Ozawa K, Kasamaki Y, Sindo A, Ohta M, et al. Effect of Age at Menopause on Blood Pressure in Postmenopausal Women. AJH 2007; 20:1045-50.

  21. Gerber LM, Lynnette Leidy, Sievert LL, Warren BA, Pickering TG, Dphil MD, et al. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause. The Journal of The North American Menopause Society. 2007;14(2):308-15.

  22. Lugones BM, Fernández-Britto RJE, Ramírez BM. Síndrome climatérico relacionado con la hipertensión arterial y otros factores de riesgo ateroscleróticos en la mujer de edad mediana. Rev Cubana Obstet Ginecol. 2007 [consultado 20 Nov 2012];33(1):1-9. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138 -600X2007000100007&lng=es&nrm=iso&tlng=es

  23. Okeahialam BN, Obeka NC. Trastorno sexual in hypertensives female. J Natl Med Assoc. 2006;98:638-40.

  24. Doumas M, Tsiokras S, Tsakiris A. Female sexual dysfunction in essential hypertension: a common problem being uncovered. J Hypertens. 2006;24:2387-92.

  25. Giachini FR, Webb RC, Tostes RC. STIM and Orai proteins: players in sexual differences in hypertension-associated vascular dysfunction. Clin Sci. 2009;118:391-6.

  26. Steinke EE. Sexual dysfunction in women with cardiovascular disease: What do we know? J Cardiovasc Nurs. 2010;570-3.

  27. Forteza Matheu A. Papel de la TH en prevención cardiovascular. Rev Iberoam Menop. 2004;6:9-12.

  28. Sofocos y lípidos elevados [consultado 20 Nov 2012]. Disponible en: http://cuidatusaludcondiane.com/los-sofocos-en-la-menopausia-asociados-a-lipidos-altos/

  29. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, D. Shah. Understanding weight gain at menopause. Climacteric. 2012 Oct;15,(5):419-29.

  30. Elenitza IM. Endocrinologic adverse effects of psychotropic drugs. Vertex. 2005;16:43-8.

  31. Camps MA, Zervos E, Goodes S, Rosemurgy AS. Impactof Bariatric Surgery on BodyImage perception and sexuality in Morbidly obese patients and theirpartners. Obes Surg. 1996;6(4):356-60.

  32. Yanes Quesada M, Cruz Hernández J, Yanes Quesada AM, Calderín Bouza R, Pardías Milán L, Vázquez Díaz. Diabetes mellitus en el anciano, un problema frecuente. Rev Cubana Med Gen Integr. 2009;25(2):1-3.

  33. Abu Ali RM, Al Hajeri RM, Khader YS, Shegem NS, Ajlouni KM. Sexual dysfunction in jordanian diabetic women. Diabetes Care. 2008;31:1580-1.

  34. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: The Framingham study. Ann Intern Med. 1976 Oct;85(4):447-52.

  35. Wimalawansa SJ. Nitric oxide: new evidence for novel therapeutic indications. Expert Opin Pharmacother. 2008;9:1935-54.

  36. Steinke EE, Mosack V, Wright DW, Chung ML, Moser DK. Risk factors as predictors of sexual activity in heart failure. Dimens Crit Care Nurs. 2009;28(3):123-9.

  37. Arpa GA, González OS, Roldós EC, Borges AH, Acosta RV. El síndrome metabólico como factor de riesgo para la disfunción endotelial. Rev Cub Med Mil. 2007 [consultado 20 Nov 2012];36(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572007000100002&nrm=iso

  38. Esposito K, Ciotola M, Giugliano F. Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res. 2007;19:486-91.

  39. Esposito K, Ciotola M, Marfella R. Sexual dysfunction in women with the metabolic syndrome. Diabetes Care. 2005;28:756.

  40. Lugones BM, Ramírez BM, Miyar PE. Las consecuencias del tabaquismo. Rev Cubana Hig Epidemiol. 2006 [consultado 4 Feb 2013];44(3). Disponible en: http://bvs.sld.cu/revistas/hie/vol44_3_06/hie07306.htm

  41. Mather KJ, Kwan F, Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril. 2000;73:150-6.

  42. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res. 1998;10(Suppl 2):84-90.




2020     |     www.medigraphic.com